3.24.0.1 html 172 235 1 false 60 0 false 5 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.rezolutebio.com/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.rezolutebio.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.rezolutebio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.rezolutebio.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Statements of Shareholders' Equity Sheet http://www.rezolutebio.com/role/StatementCondensedConsolidatedStatementsOfShareholdersEquity Condensed Consolidated Statements of Shareholders' Equity Statements 5 false false R6.htm 00400 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.rezolutebio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.rezolutebio.com/role/DisclosureNatureOfOperationsAndSummaryOfSignificantAccountingPolicies NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 10201 - Disclosure - LIQUIDITY Sheet http://www.rezolutebio.com/role/DisclosureLiquidity LIQUIDITY Notes 8 false false R9.htm 10301 - Disclosure - INVESTMENTS IN MARKETABLE DEBT SECURITIES Sheet http://www.rezolutebio.com/role/DisclosureInvestmentsInMarketableDebtSecurities INVESTMENTS IN MARKETABLE DEBT SECURITIES Notes 9 false false R10.htm 10401 - Disclosure - OPERATING LEASES Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeases OPERATING LEASES Notes 10 false false R11.htm 10501 - Disclosure - LICENSE AGREEMENTS Sheet http://www.rezolutebio.com/role/DisclosureLicenseAgreements LICENSE AGREEMENTS Notes 11 false false R12.htm 10601 - Disclosure - EMBEDDED DERIVATIVE LIABILITY Sheet http://www.rezolutebio.com/role/DisclosureEmbeddedDerivativeLiability EMBEDDED DERIVATIVE LIABILITY Notes 12 false false R13.htm 10701 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://www.rezolutebio.com/role/DisclosureShareholdersEquity SHAREHOLDERS' EQUITY Notes 13 false false R14.htm 10801 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrants SHARE-BASED COMPENSATION AND WARRANTS Notes 14 false false R15.htm 10901 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.rezolutebio.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 15 false false R16.htm 11001 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.rezolutebio.com/role/DisclosureRelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 16 false false R17.htm 11101 - Disclosure - INCOME TAXES Sheet http://www.rezolutebio.com/role/DisclosureIncomeTaxes INCOME TAXES Notes 17 false false R18.htm 11201 - Disclosure - NET LOSS PER SHARE Sheet http://www.rezolutebio.com/role/DisclosureNetLossPerShare NET LOSS PER SHARE Notes 18 false false R19.htm 11301 - Disclosure - FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS Sheet http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrations FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS Notes 19 false false R20.htm 11401 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.rezolutebio.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS Notes 20 false false R21.htm 20102 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.rezolutebio.com/role/DisclosureNatureOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 21 false false R22.htm 30303 - Disclosure - INVESTMENTS IN MARKETABLE DEBT SECURITIES (Tables) Sheet http://www.rezolutebio.com/role/DisclosureInvestmentsInMarketableDebtSecuritiesTables INVESTMENTS IN MARKETABLE DEBT SECURITIES (Tables) Tables http://www.rezolutebio.com/role/DisclosureInvestmentsInMarketableDebtSecurities 22 false false R23.htm 30403 - Disclosure - OPERATING LEASES (Tables) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesTables OPERATING LEASES (Tables) Tables http://www.rezolutebio.com/role/DisclosureOperatingLeases 23 false false R24.htm 30703 - Disclosure - SHAREHOLDERS' EQUITY (Tables) Sheet http://www.rezolutebio.com/role/DisclosureShareholdersEquityTables SHAREHOLDERS' EQUITY (Tables) Tables http://www.rezolutebio.com/role/DisclosureShareholdersEquity 24 false false R25.htm 30803 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS (Tables) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsTables SHARE-BASED COMPENSATION AND WARRANTS (Tables) Tables http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrants 25 false false R26.htm 31203 - Disclosure - NET LOSS PER SHARE (Tables) Sheet http://www.rezolutebio.com/role/DisclosureNetLossPerShareTables NET LOSS PER SHARE (Tables) Tables http://www.rezolutebio.com/role/DisclosureNetLossPerShare 26 false false R27.htm 31303 - Disclosure - FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS (Tables) Sheet http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrationsTables FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS (Tables) Tables http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrations 27 false false R28.htm 40101 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.rezolutebio.com/role/DisclosureNatureOfOperationsAndSummaryOfSignificantAccountingPoliciesDetails NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.rezolutebio.com/role/DisclosureNatureOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies 28 false false R29.htm 40201 - Disclosure - LIQUIDITY (Details) Sheet http://www.rezolutebio.com/role/DisclosureLiquidityDetails LIQUIDITY (Details) Details http://www.rezolutebio.com/role/DisclosureLiquidity 29 false false R30.htm 40301 - Disclosure - INVESTMENTS IN MARKETABLE DEBT SECURITIES - Investments in marketable securities (Details) Sheet http://www.rezolutebio.com/role/DisclosureInvestmentsInMarketableDebtSecuritiesInvestmentsInMarketableSecuritiesDetails INVESTMENTS IN MARKETABLE DEBT SECURITIES - Investments in marketable securities (Details) Details 30 false false R31.htm 40302 - Disclosure - INVESTMENTS IN MARKETABLE DEBT SECURITIES - Additional Information (Details) Sheet http://www.rezolutebio.com/role/DisclosureInvestmentsInMarketableDebtSecuritiesAdditionalInformationDetails INVESTMENTS IN MARKETABLE DEBT SECURITIES - Additional Information (Details) Details 31 false false R32.htm 40303 - Disclosure - INVESTMENTS IN MARKETABLE DEBT SECURITIES - Cash and cash equivalents and marketable securities held (Details) Sheet http://www.rezolutebio.com/role/DisclosureInvestmentsInMarketableDebtSecuritiesCashAndCashEquivalentsAndMarketableSecuritiesHeldDetails INVESTMENTS IN MARKETABLE DEBT SECURITIES - Cash and cash equivalents and marketable securities held (Details) Details 32 false false R33.htm 40401 - Disclosure - OPERATING LEASES - Additional Information (Details) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesAdditionalInformationDetails OPERATING LEASES - Additional Information (Details) Details 33 false false R34.htm 40402 - Disclosure - OPERATING LEASES - Assets and operating lease liabilities (Details) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesAssetsAndOperatingLeaseLiabilitiesDetails OPERATING LEASES - Assets and operating lease liabilities (Details) Details 34 false false R35.htm 40403 - Disclosure - OPERATING LEASES - Operating lease expense (Details) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesOperatingLeaseExpenseDetails OPERATING LEASES - Operating lease expense (Details) Details 35 false false R36.htm 40404 - Disclosure - OPERATING LEASES - Future Operating Lease Payments (Details) Sheet http://www.rezolutebio.com/role/DisclosureOperatingLeasesFutureOperatingLeasePaymentsDetails OPERATING LEASES - Future Operating Lease Payments (Details) Details 36 false false R37.htm 40501 - Disclosure - LICENSE AGREEMENTS (Details) Sheet http://www.rezolutebio.com/role/DisclosureLicenseAgreementsDetails LICENSE AGREEMENTS (Details) Details http://www.rezolutebio.com/role/DisclosureLicenseAgreements 37 false false R38.htm 40601 - Disclosure - EMBEDDED DERIVATIVE LIABILITY (Details) Sheet http://www.rezolutebio.com/role/DisclosureEmbeddedDerivativeLiabilityDetails EMBEDDED DERIVATIVE LIABILITY (Details) Details http://www.rezolutebio.com/role/DisclosureEmbeddedDerivativeLiability 38 false false R39.htm 40701 - Disclosure - SHAREHOLDERS' EQUITY - Changes in Shareholders' Equity (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareholdersEquityChangesInShareholdersEquityDetails SHAREHOLDERS' EQUITY - Changes in Shareholders' Equity (Details) Details 39 false false R40.htm 40702 - Disclosure - SHAREHOLDERS EQUITY - Jefferies Open Market Sales Agreement (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareholdersEquityJefferiesOpenMarketSalesAgreementDetails SHAREHOLDERS EQUITY - Jefferies Open Market Sales Agreement (Details) Details 40 false false R41.htm 40703 - Disclosure - SHAREHOLDERS' EQUITY - 2022 Class B PFW Exercise (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareholdersEquity2022ClassBPfwExerciseDetails SHAREHOLDERS' EQUITY - 2022 Class B PFW Exercise (Details) Details 41 false false R42.htm 40704 - Disclosure - SHAREHOLDERS' EQUITY - 2022 Private Placement (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareholdersEquity2022PrivatePlacementDetails SHAREHOLDERS' EQUITY - 2022 Private Placement (Details) Details 42 false false R43.htm 40801 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Stock Option Plans (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsStockOptionPlansDetails SHARE-BASED COMPENSATION AND WARRANTS - Stock Option Plans (Details) Details 43 false false R44.htm 40802 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Stock Options Outstanding (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsStockOptionsOutstandingDetails SHARE-BASED COMPENSATION AND WARRANTS - Stock Options Outstanding (Details) Details 44 false false R45.htm 40803 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Weighted Average Assumptions (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsWeightedAverageAssumptionsDetails SHARE-BASED COMPENSATION AND WARRANTS - Weighted Average Assumptions (Details) Details 45 false false R46.htm 40804 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Share Based Compensation Expense (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsShareBasedCompensationExpenseDetails SHARE-BASED COMPENSATION AND WARRANTS - Share Based Compensation Expense (Details) Details 46 false false R47.htm 40805 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Additional Information (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsAdditionalInformationDetails SHARE-BASED COMPENSATION AND WARRANTS - Additional Information (Details) Details 47 false false R48.htm 40806 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Summary of Other Warrants (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsSummaryOfOtherWarrantsDetails SHARE-BASED COMPENSATION AND WARRANTS - Summary of Other Warrants (Details) Details 48 false false R49.htm 40807 - Disclosure - SHARE-BASED COMPENSATION AND WARRANTS - Pre-Funded Warrants (Details) Sheet http://www.rezolutebio.com/role/DisclosureShareBasedCompensationAndWarrantsPreFundedWarrantsDetails SHARE-BASED COMPENSATION AND WARRANTS - Pre-Funded Warrants (Details) Details 49 false false R50.htm 41001 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.rezolutebio.com/role/DisclosureRelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.rezolutebio.com/role/DisclosureRelatedPartyTransactions 50 false false R51.htm 41201 - Disclosure - NET LOSS PER SHARE - Weighted Average Number of Shares Outstanding (Details) Sheet http://www.rezolutebio.com/role/DisclosureNetLossPerShareWeightedAverageNumberOfSharesOutstandingDetails NET LOSS PER SHARE - Weighted Average Number of Shares Outstanding (Details) Details 51 false false R52.htm 41202 - Disclosure - NET LOSS PER SHARE - Anti-dilutive (Details) Sheet http://www.rezolutebio.com/role/DisclosureNetLossPerShareAntiDilutiveDetails NET LOSS PER SHARE - Anti-dilutive (Details) Details 52 false false R53.htm 41301 - Disclosure - FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Fair value on a recurring basis (Details) Sheet http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrationsFairValueOnRecurringBasisDetails FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Fair value on a recurring basis (Details) Details 53 false false R54.htm 41302 - Disclosure - FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Summary of Changes in the Fair Value (Details) Sheet http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrationsSummaryOfChangesInFairValueDetails FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Summary of Changes in the Fair Value (Details) Details 54 false false R55.htm 41303 - Disclosure - FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Additional Information (Details) Sheet http://www.rezolutebio.com/role/DisclosureFinancialInstrumentsAndSignificantConcentrationsAdditionalInformationDetails FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Additional Information (Details) Details 55 false false R56.htm 41401 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.rezolutebio.com/role/DisclosureSubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://www.rezolutebio.com/role/DisclosureSubsequentEvents 56 false false R57.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Uncategorized 57 false false R58.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Cover 58 false false All Reports Book All Reports rzlt-20231231.xsd rzlt-20231231_cal.xml rzlt-20231231_def.xml rzlt-20231231_lab.xml rzlt-20231231_pre.xml rzlt-20231231x10q.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true